| Authors: |
Li CF; Department of Molecular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. cli14@mdanderson.org.; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. cli14@mdanderson.org., Wei Y; Department of Molecular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lee HH; Department of Molecular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Chang WC; Center for Molecular Medicine, China Medical University Hospital, China Medical University, Taichung, Taiwan., Xiong Y; Proteomics Core Facility, Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Tang Y; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Yang R; Department of Molecular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; The AHMC Dermatology and Research Center, Arcadia, CA, USA., Yao J; Department of Molecular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wang H; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wang X; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Liu M; Department of Molecular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Park J; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Fu J; Department of Molecular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wang YN; Department of Molecular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Bai LY; Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, and China Medical University, Taichung, Taiwan., Wang SC; Center for Molecular Medicine, China Medical University Hospital, China Medical University, Taichung, Taiwan.; Graduate Institute of Biomedical Sciences, College of Medicine, and Institute of Biochemistry and Molecular Biology, College of Life Sciences, China Medical University, Taichung, Taiwan.; Research Center for Cancer Biology, China Medical University, Taichung, Taiwan.; Department of Biotechnology, Asia University, Taichung, Taiwan., Chou CW; Department of Molecular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Graduate Institute of Biomedical Sciences, College of Medicine, and Institute of Biochemistry and Molecular Biology, College of Life Sciences, China Medical University, Taichung, Taiwan.; Division of Hematology/Medical Oncology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan., Ling J; Department of Molecular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Chu YY; Department of Molecular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Xun Z; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Liang H; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Maitra A; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Yao W; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; The University of Texas MD Anderson UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA., Yu D; Department of Molecular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; The University of Texas MD Anderson UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA., Chiao PJ; Department of Molecular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; The University of Texas MD Anderson UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA., Ying H; Department of Molecular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. HYing@mdanderson.org.; The University of Texas MD Anderson UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA. HYing@mdanderson.org., Hung MC; Department of Molecular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. mhung@cmu.edu.tw.; Center for Molecular Medicine, China Medical University Hospital, China Medical University, Taichung, Taiwan. mhung@cmu.edu.tw.; Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, and China Medical University, Taichung, Taiwan. mhung@cmu.edu.tw.; Graduate Institute of Biomedical Sciences, College of Medicine, and Institute of Biochemistry and Molecular Biology, College of Life Sciences, China Medical University, Taichung, Taiwan. mhung@cmu.edu.tw.; Research Center for Cancer Biology, China Medical University, Taichung, Taiwan. mhung@cmu.edu.tw. |
